Results 241 to 250 of about 91,755 (270)
Some of the next articles are maybe not open access.

Nivolumab

Reactions Weekly, 2021
openaire   +1 more source

Open-Label Phase II Study of the Efficacy of Nivolumab for Cancer of Unknown Primary

Annals of Oncology, 2022
Shin Takahashi, Y Takiguchi, J Tanizaki
exaly  

Home - About - Disclaimer - Privacy